Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shane Miersch

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
ACS Chemical Biology|June 22, 2022
Peptide-Antibody Fusions Engineered by Phage Display Exhibit an Ultrapotent and Broad Neutralization of SARS-CoV-2 VariantsJonathan M Labriola, Shane Miersch, Gang Chen, et al.
Heliyon|April 6, 2023
Nebulization of pharmacological solutions with an innovative medical device based on microvaporizationBruno Brandimarte, Lino Di Rienzo Businco, Francesco Cappello, et al.
Plos Pathogens|December 22, 2022
Ubiquitin variants potently inhibit SARS-CoV-2 PLpro and viral replication via a novel site distal to the protease active siteVera J E van Vliet, Nhan Huynh, Judith Palà, et al.
Molecular & Cellular Proteomics : MCP|August 21, 2015
A High Through-put Platform for Recombinant Antibodies to Folded ProteinsMichael Hornsby, Marcin Paduch, Shane Miersch, et al.
Biorxiv : the Preprint Server for Biology|January 5, 2021
Tetravalent SARS-CoV-2 Neutralizing Antibodies Show Enhanced Potency and Resistance to Escape MutationsShane Miersch, Zhijie Li, Reza Saberianfar, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Neutralizing antibody and soluble ACE2 inhibition of a replication-competent VSV-SARS-CoV-2 and a clinical isolate of SARS-CoV-2James Brett Case, Paul W Rothlauf, Rita E Chen, et al.
Cell Host & Microbe|August 1, 2020
Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2James Brett Case, Paul W Rothlauf, Rita E Chen, et al.
Journal of Molecular Biology|July 30, 2021
Tetravalent SARS-CoV-2 Neutralizing Antibodies Show Enhanced Potency and Resistance to Escape MutationsShane Miersch, Zhijie Li, Reza Saberianfar, et al.
SSRN|July 28, 2020
Neutralizing antibody and soluble ACE2 inhibition of a replication-competent VSV-SARS-CoV-2 and a clinical isolate of SARS-CoV-2James Brett Case, Paul W Rothlauf, Rita E Chen, et al.
Communications Biology|April 13, 2021
Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2Kushal Suryamohan, Devan Diwanji, Eric W Stawiski, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
ACS Chemical Biology|June 22, 2022
Peptide-Antibody Fusions Engineered by Phage Display Exhibit an Ultrapotent and Broad Neutralization of SARS-CoV-2 VariantsJonathan M Labriola, Shane Miersch, Gang Chen, et al.
Heliyon|April 6, 2023
Nebulization of pharmacological solutions with an innovative medical device based on microvaporizationBruno Brandimarte, Lino Di Rienzo Businco, Francesco Cappello, et al.
Plos Pathogens|December 22, 2022
Ubiquitin variants potently inhibit SARS-CoV-2 PLpro and viral replication via a novel site distal to the protease active siteVera J E van Vliet, Nhan Huynh, Judith Palà, et al.
Molecular & Cellular Proteomics : MCP|August 21, 2015
A High Through-put Platform for Recombinant Antibodies to Folded ProteinsMichael Hornsby, Marcin Paduch, Shane Miersch, et al.
Biorxiv : the Preprint Server for Biology|January 5, 2021
Tetravalent SARS-CoV-2 Neutralizing Antibodies Show Enhanced Potency and Resistance to Escape MutationsShane Miersch, Zhijie Li, Reza Saberianfar, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Neutralizing antibody and soluble ACE2 inhibition of a replication-competent VSV-SARS-CoV-2 and a clinical isolate of SARS-CoV-2James Brett Case, Paul W Rothlauf, Rita E Chen, et al.
Cell Host & Microbe|August 1, 2020
Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2James Brett Case, Paul W Rothlauf, Rita E Chen, et al.
Journal of Molecular Biology|July 30, 2021
Tetravalent SARS-CoV-2 Neutralizing Antibodies Show Enhanced Potency and Resistance to Escape MutationsShane Miersch, Zhijie Li, Reza Saberianfar, et al.
SSRN|July 28, 2020
Neutralizing antibody and soluble ACE2 inhibition of a replication-competent VSV-SARS-CoV-2 and a clinical isolate of SARS-CoV-2James Brett Case, Paul W Rothlauf, Rita E Chen, et al.
Communications Biology|April 13, 2021
Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2Kushal Suryamohan, Devan Diwanji, Eric W Stawiski, et al.
Pageof 5